http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20080050453-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D285-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
filingDate 2006-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7725c10f9e214847d7445b28c096a729
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1611eb0dca0bb547aebbd1f7dde0b475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_433baaf1967095518879ed7814ac55fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_836c1377ba17debe7093ca29835335bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64adb542aa74b3ed6bca7a4a6ddd65a0
publicationDate 2008-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20080050453-A
titleOfInvention Benzothiadiazolylphenylalkylamine derivatives for use in the treatment of diseases improved by monoamine resorption
abstract The present invention relates to a benzothiadiazolylphenylalkylamine derivative of formula (I) or a pharmaceutically acceptable salt thereof, a composition containing the derivative, and a disease ameliorated by monoamine resorption, inter alia, vascular dysfunction symptoms (VMS) Diseases, including sexual dysfunction, gastrointestinal and urogenital disorders, chronic fatigue syndrome, fibromyalgia syndrome, nervous system disorders, and combinations thereof, especially major depressive disorders, vasomotor symptoms, stressful and urinary incontinence, fibromyalgia, pain , Diabetic neuropathy, and combinations thereof, and methods for use thereof for the prevention and treatment of diseases selected from the group consisting of.n n n <Formula I>
priorityDate 2005-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157754873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448379295

Total number of triples: 33.